Notice of NINDS Specific Interest in AD/ADRD for PAS-22-196 "Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)" (NOT-NS-23-049)

Sponsor: National Institute of Neurological Disorders and Stroke

Notice of NINDS Specific Interest in AD/ADRD for PAS-22-197 "Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)" (NOT-NS-23-050)

Sponsor: National Institute of Neurological Disorders and Stroke

Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional) (PAR-23-054)

Sponsor: National Institute on Aging, Office of Research on Women's Health

Due Date: Multiple due dates; see announcement.

Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional) (PAR-23-053)

Sponsor: National Institute on Aging, Office of Research on Women's Health

Due Date: Multiple due dates; see announcement.

INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Research Short Course (R25 Independent Clinical Trial Not Allowed) (PAR-22-195)

Sponsor: National Institutes of Health

Award: Application budgets may not exceed $400,000 in direct costs annually. The maximum project period is 5 years.

Due Date: Multiple due dates; see announcement.

Notice of Special Interest: Development of Radiotracers for Diagnosis and Clinical Studies in Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (NOT-AG-22-032)

Sponsor: National Institute on Aging

Due Date: See announcement for due dates and associated Funding Opportunity Announcements.

Resource-Related Research Projects for Development of Animal Models and Related Materials (R24 Clinical Trials Not-Allowed) (RFA-OD-22-013)

Sponsor: National Institutes of Health

Award: The National Institutes of Health (NIH) intends to commit $5,000,000 per fiscal year in FY 2023-2026 to fund at least six awards per fiscal year.

Due Date: Multiple due dates; see announcement.

Notice of Special Interest (NOSI): Research on the Health of Bisexual and Bisexual+ People (NOT-OD-22-166)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Notice of Special Interest (NOSI): Addressing Evidence Gaps in Screening (NOT-OD-22-179)

Sponsor: National Institutes of Health

Due Date: See announcement.

Notice of Special Interest (NOSI): Increasing Uptake of Evidence-Based Screening in Diverse Populations Across the Lifespan (NOT-OD-22-178)

Sponsor: National Institutes of Health

Due Date: See announcement.

Notice of Special Interest: Availability of Administrative Supplements for INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) (NOT-OD-22-137)

Sponsor: National Institutes of Health

Due Date: See announcement.

NIDA, NIMH, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional) (PAR-22-181)

Sponsor: National Institutes of Health

Award: NINDS intends to commit up to $10 million per fiscal year, approximately 25 awards, dependent on award amounts.

Due Date: Multiple due dates; see announcement.

Prospective Observational Comparative Effectiveness Research in Clinical Neurosciences (UG3/UH3 Clinical Trial Not Allowed) (PAR-22-076)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Multiple due dates; see announcement.

Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed) (PAR-22-126)

Sponsor: National Institutes of Health

Due Date: Multiple due dates, see announcement.

Focused Technology Research and Development (R01 Clinical Trial Not Allowed) (PAR-22-127)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.